Sentinext Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Sentinext Therapeutics General Information

Description

Developer of safe and efficacious vaccines intended to be used for treating tropical infectious diseases. The company's safe and efficacious vaccines are effective for the treatment of tropical infectious diseases such as EV71, polio, influenza and dengue, enabling healthcare institutions to avail enhanced drugs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Suite 19-H, Level 19
  • Menara Northam, 55 Jalan Sultan Ahmad Shah
  • Penang, 10050
  • Malaysia
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • Suite 19-H, Level 19
  • Menara Northam, 55 Jalan Sultan Ahmad Shah
  • Penang, 10050
  • Malaysia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentinext Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Apr-2018 Completed Out of Business
4. Later Stage VC (Series B2) 25-Jan-2018 Completed Generating Revenue
3. Early Stage VC (Series B1) 06-Nov-2014 Completed Startup
2. Early Stage VC (Series B) 25-Dec-2011 $6.34M $17.9M Completed Startup
1. Early Stage VC (Series A) 08-Oct-2009 $11.6M $11.6M Completed Startup
To view Sentinext Therapeutics’s complete valuation and funding history, request access »

Sentinext Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series B 6,666,694 $0.95 $0.95 1x $0.95 21.79%
Series A 7,020,199 $0.89 $0.89 1x $0.89 22.94%
To view Sentinext Therapeutics’s complete cap table history, request access »

Sentinext Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of safe and efficacious vaccines intended to be used for treating tropical infectious diseases. The company's
Biotechnology
Penang, Malaysia
11 As of 2016

Lausanne, Switzerland

Beijing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sentinext Therapeutics Competitors (5)

One of Sentinext Therapeutics’s 5 competitors is AB2 Bio, a Venture Capital-Backed company based in Lausanne, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AB2 Bio Venture Capital-Backed Lausanne, Switzerland
Sinovac Biotech Corporation Beijing, China
GeoVax Labs Corporation Smyrna, GA
Cytodyn Formerly Angel backed Vancouver, WA
aVaxMed Venture Capital-Backed Abingdon, United Kingdom
You’re viewing 5 of 5 competitors. Get the full list »

Sentinext Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sentinext Therapeutics FAQs

  • When was Sentinext Therapeutics founded?

    Sentinext Therapeutics was founded in 2008.

  • Where is Sentinext Therapeutics headquartered?

    Sentinext Therapeutics is headquartered in Penang, Malaysia.

  • What is the size of Sentinext Therapeutics?

    Sentinext Therapeutics has 11 total employees.

  • What industry is Sentinext Therapeutics in?

    Sentinext Therapeutics’s primary industry is Biotechnology.

  • Is Sentinext Therapeutics a private or public company?

    Sentinext Therapeutics is a Private company.

  • What is Sentinext Therapeutics’s current revenue?

    The current revenue for Sentinext Therapeutics is .

  • How much funding has Sentinext Therapeutics raised over time?

    Sentinext Therapeutics has raised $33.5M.

  • Who are Sentinext Therapeutics’s competitors?

    AB2 Bio, Sinovac Biotech, GeoVax Labs, Cytodyn, and aVaxMed are competitors of Sentinext Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process